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Abstract
Mechanical factors such as stretch are thought to be important in the regulation of muscle phenotype. Small muscle protein
X-linked (SMPX) is upregulated by stretch in skeletal muscle and has been suggested to serve both as a transcription factor
and a mechanosensor, possibly giving rise to changes in both fiber size and fiber type. We have used in vivo confocal
imaging to study the subcellular localization of SMPX in skeletal muscle fibers of adult rats using a SMPX-EGFP fusion
protein. The fusion protein was localized predominantly in repetitive double stripes flanking the Z-disc, and was excluded
from all nuclei. This localization would be consistent with SMPX being a mechanoreceptor, but not with SMPX playing a role
as a transcription factor. In vivo overexpression of ectopic SMPX in skeletal muscle of adult mice gave no significant changes
in fiber type distribution or cross sectional area, thus a role of SMPX in regulating muscle phenotype remains unclear.
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Introduction
Skeletal muscle displays a remarkable ability to adapt to
variable conditions such as electrical activity, hormones and
mechanical load. Nerve evoked electrical activity is perhaps the
most important stimulus for changing muscle phenotype [1,2,3],
and the effect of hormones, particularly anabolic steroids, is well
known to cause dramatic changes in skeletal muscle tissue
[4,5,6,7]. How muscle cells sense and respond to changes in
mechanical load has, however, not been investigated to the same
extent as the factors mentioned above, and numerous candidate
proteins have been suggested as mechanosensors both in cardiac
and skeletal muscle [8]. The most likely candidate structure for
mechanotransduction in muscle cells are the costameres, demon-
strated to be important for lateral force transmission during muscle
contraction [9]. These are cytoskeletal protein complexes arranged
so that they flank the Z-line and overlie the I-band of sarcomeres
and anchor the sarcomeres to the extracellular matrix [10].
One of the candidate proteins for mechanotransduction is Small
Muscle Protein X-linked (SMPX), a 9 kD protein predominantly
expressed in cardiac and skeletal muscle. It is highly conserved in
mammals and is upregulated in skeletal muscle during passive
stretch [11,12]. SMPX is located to the costameres, but has not
been verified to play a definite role as a mechanosensor in muscle.
However, it has been suggested that SMPX might increase the
adhesive function of integrins [13], suggesting a role as an indirect
mechanotransductor. Additionally, SMPX is localized to the
costameres, both in vivo and in C2C12 cells [14], and it co-
precipitates with vinculin, a major constituent of the costameres
[10,13].
From a phenotypic perspective, SMPX has been thought to be a
candidate gene in regulating muscle size. Schindeler et al. (2005)
found that SMPX may participate in the regulation of cytoskeletal
dynamics through the Rac1/p38 pathway, a pathway involved in
mechanosensing in other tissues [15]. Additionally, differentiating
C2C12 myoblasts overexpressing SMPX increase their suscepti-
bility to fuse, forming large ‘‘myosacs’’ in an IGF-1 dependent
manner [14]. This further indicates a role for SMPX in the
regulation of fiber size.
SMPX has also been suggested to regulate another key
phenotype in skeletal muscle: Putative binding sites for several
muscle-specific transcription factors has been found in the
promoter region located immediately 59 to the Smpx gene,
including MyoD and MEF-2 [11,12,14], indicating that SMPX
could be regulated by one or both of these myogenic factors.
Overexpression of SMPX in cultured C2C12 muscle cells leads to
activation of the transcription factors MEF2 and NFAT in an IGF-
1 dependent manner. Both MEF2 and NFAT are key players in
muscle differentiation [16,17] and are implicated in regulating
gene expression associated with fiber type changes [2].
NFAT also regulates several genes involved in the determina-
tion of muscle phenotype [18,19] and is predominantly active in
slow fibers [18,19]. SMPX itself is enriched in slow fibers [14],
which led us to the hypothesis that increased levels of SMPX in
adult skeletal muscle could induce a shift towards a ‘‘slow’’ muscle
phenotype. Also, SMPX might play a role in inducing hypertro-
phy in adult skeletal muscle by increasing the cells’ sensitivity to
mechanical strain.
Here, we describe the intracellular localization of a SMPX-
EGFP fusion protein in adult murine muscle fibers in sedentary
and functionally overloaded animals. We also show that overex-
pression of the untagged protein in vivo does not change the
phenotype of the muscle cells, with regard to size and MyHC fiber
type composition.
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Methods
Plasmids
In order to study the subcellular localization of SMPX, a fusion
protein expressing SMPX in frame with EGFP (pEGFP-N1-Smpx)
was made. Smpx was inserted at the N-terminal end of EGFP in the
plasmid pEGFP-N1 (Clontech). We verified the expression of the
SMPX-EGFP fusion protein by western blotting of transfected
HEK-293 cells, with a band at the predicted size of approximately
40 kD, using a mouse antibody against GFP (Invitrogen). The
negative control and EGFP only control showed no band at the
correct size (Figure 1A). To induce in vivo overexpression of SMPX
in adult muscle fibers, EGFP and Smpx driven by separate CMV
promoters on the same plasmid (pCMS-EGFP-Smpx) were used.
The contralateral leg was transfected with pCMS-EGFP (Clon-
tech), serving as a sham control. For the fiber type and cross
sectional area analysis a reporter plasmid (pAP-lacZ, gift from N.
Gautam) expressing b-galactosidase (b-gal) was used to detect
transfected fibers, since EGFP is difficult to detect on cryosections.
b-gal was driven by the RSV promoter, while the SMPX-EGFP
fusion protein, SMPX and EGFP were all driven by the CMV
promoter.
Cell culture
HEK-293 cells (ATCC: CRL-1573) were grown in DMEM
(GIBCO) containing 10% fetal calf serum (Bio Whittaker) and
100 U/ml penicillin and streptomycin. C2C12 cells (ATCC:
CRL-1772) were grown as the HEK-293 cells, but with 20% fetal
calf serum to maintain the cells in an undifferentiated myoblast
stage. All cells were grown with a set temperature of 37uC, a CO2
level of 5% and humidity of 100%.
All transfections were done using FuGENE 6 (Roche) according
to manufacturers instructions. As a sham control, one well was
always transfected with the pCMS-EGFP-N1 plasmid without
Smpx inserted. Transfection without any plasmid was used as a
negative control (data not shown). All cell culture images shown
were obtained 1 day after transfection, with Hoechst 33342 added
to the media to visualize nuclei.
Protein analysis
Transfected HEK293 cells were washed twice with ice cold PBS
and lysed with lysis buffer A: (50 mM tris acetate, 0.27 M sucrose,
1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate,
10 mM a-glycerophosphate, 50 mM sodium fluoride, 5 mM
sodium pyrophosphate, 1% (w/v) Triton X100, 0.2 mM PMSF,
1 mM benzamidine and 0.1% (v/v) b-mercaptoethanol). The
lysates were then centrifuged at 4uC and 13000G for 20 minutes
and the supernatant saved. Protein concentration was then
measured at 595 nm using a Bradford assay on Victor 2 (Wallac).
30 mg of protein was run on NuPAGE Novex Bis-Tris 4–12% Gels
(Invitrogen), followed by Western blotting (NuPAGE Western
Transfer Protocol, Invitrogen). Blots were developed using the
ECL Western Blotting Detection kit (Amersham) according to the
manufacturer’s instructions. A mouse anti-GFP antibody (Invitro-
gen) was used to detect SMPX-EGFP and EGFP (Figure 1A).
Expression of pCMS-EGFP-Smpx was verified with northern
blotting on HEK-293 cells (data not shown)
Animal experiments
The surgical procedures were performed either with male
Wistar rats weighing 300–400 g for the localization experiments or
with NMRI mice weighing 20–30 g for the isolated whole muscle
localization and overexpression experiments. All animals were
under deep anaesthesia induced either by ForeneH gas (Isoflurane,
Abbott) or by intraperitoneal injections of 5 ml g21 Equithesin
(Veso Pharmacy, Norwegian School of Veterinary Science,
Norway). In order to overload the extensor digitorum longus muscle
(EDL), approximately two-thirds of the distal end of the tibialis
anterior muscle was excised. The animals were euthanized by
cervical dislocation while anaesthetised. The animal procedures
were reviewed and approved by the Norwegian Animal Research
Authority and were conducted in accordance with the Norwegian
Animal Welfare Act of December 20th, 1974, no. 37, chapter VI,
sections 20–22, and the Regulation of Animal Experimentation of
January 15th, 1996.
In vivo protein expression
In vivo electroporation with DNA was performed essentially as
described previously [20], with some modifications. The muscle
was surgically exposed, and 10 ml of DNA solution (1 mg/ml in
0.9% NaCl) was injected into the belly of the muscle. An electrical
field was then applied to the muscle using a pulse-generator (Pulsar
6bp-a/s, FHC inc., USA), using five trains of 1000 symmetrical
bipolar square pulses lasting 200 ms in each polarity direction, with
total amplitude of 20 V for mice and 100 V for rats.
Figure 1. Expression of SMPX plasmids, in vitro and in vivo. A)
Western blot of SMPX-EGFP expression in HEK-293 cells stained with
antibodies against EGFP. Lane 1: Negative control. Lane 2: EGFP only.
Lane 3-6: SMPX-EGFP. B) In vivo fluorescence image of EDL muscle
expressing pCMS-EGFP-Smpx. Scalebar is 500 microns. Inset: High
magnification of single fibers. Scalebar is 50 microns. C) b-gal (left) and
myosin heavy chain type 2A (right) stain on neighboring cross-sections
from the same muscle as in B). b-gal expressing fibers marked with
asterisks. Scale bar is 50 microns.
doi:10.1371/journal.pone.0099232.g001
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Immunohistochemistry
Sections. Muscles were frozen by submersion in melting
isopentane in a slightly stretched condition, and histological
analyses of b -gal, MyHC fiber type composition and CSA were
determined 14 days after electroporation on 10 mm transverse
serial sections, essentially as described previously [21]. MyHC
fiber type was determined using the monoclonal antibodies BA-D5
(I), SC-71 (IIa), BF-35 (non-IIx) and BF-F3 (IIb) (Schiaffino et al.
1989) with the secondary antibody Anti-mouse IgG-FITC (F-
9137, Sigma) for MyHC I, IIa and non-IIx, and Anti-mouse IgM-
Cy3 (J115-165-020, Jackson Immuno Research) for MyHC IIb.
Single fibers. Rat EDL were electroporated with pEGFP-
N1-SMPX or the sham plasmid pEGFP-N1. 24-36 hours after
transfection muscles were isolated and placed in ringer solution
with an electrolyte composition of (in mM) 2 CaCl2 110 NaCl, 5
KCl, 1 MgCl, 25 NaHCO, 11 glucose, 0.3 glutamic acid, 0.4
glutamine, 5 HEPES bubbled with 5% CO2/95% O2 and placed
under a Confocal microscope for in situ imaging of SMPX-EGFP.
The muscles were immediately after imaging injected with 1%
paraformaldehyde and fixed in 4uC over night. Muscles were then
washed in PBS and placed under a fluorescence microscope. Small
fiber bundles were mechanically free dissected and placed in
permeabilization-buffer (50 mM glycine, 0.25% BSA, 0.04%
saponin in 0.01 M PBS) for 2.5 hours at room temperature, and
then stained with Alexa Fluor 680 Phalloidin (Invitrogen) in
staining solution (1% BSA, 0.5% Triton X-100 in 0.01 M PBS) for
1.5 hours at 32uC. Fibers were then washed 3 times 30 minutes in
staining solution without any antibody present and mounted on
slides with ProlongGold antifade agent with DAPI (Invitrogen,
Oregon, USA). Non-fluorescent fibers were used as negative
controls (data not shown). (Modified protocol from Averbeck et al.,
2007).
Confocal microscopy
Imaging with a confocal microscope (Olympus BX61WI,
Tokyo, Japan) connected to an imaging system (Olympus fluoview
FV1000, Olympus, Europe GmBH) was performed either in situ or
on isolated fibers from the SMPX-EGFP fusion protein experi-
ments. All images were taken with either a 60X water
(LUMPlanFI, NA 0.9) (used in vivo and in situ) or a 100X oil
(UPlan Apo, NA 1.35 oil Iris) (used in vitro) immersion objective.
Images were further processed in Photoshop CS3- or CS5-
extended version (Adobe Systems, San Jose, CA, USA).
Mouse EDL muscle were electroporated with pEGFP-N1-
SMPX either without or with overloading by synergist ablation of
the tibialis anterior muscle. After confirming fluorescence in vivo (data
not shown), muscles were placed in a 4% paraformaldehyde
solution with Hoechst 33342 and further imaged with a confocal
microscope.
Statistical analyses
All statistical calculations were done in Prism4 (GraphPad
Software Inc., San Diego, CA, USA), with a level of significance
set to 5%. The fiber type distribution in sham control and SMPX
muscle fibers were compared using a chi- square test. The CSA
measurements were compared using a Students t-test.
Results
Nuclear localization
Our results show that SMPX-EGFP did not accumulate in the
nuclei in cell culture (Figure 2A), levels were below those in the
cytosol. In adult skeletal muscle fibers, SMPX-EGFP was not seen
above background levels in any investigated nuclei (Figure 2B). In
the control experiments with EGFP alone, the signal was localized
to the nuclei in much the same intensity as in the cytosol, i.e. no
accumulation of protein in the nucleus. The fusion protein was
also excluded from the nuclei after 18 hours of overload (2C). As
has been described in earlier reports we noticed an increased level
of SMPX in the perinuclear area. This was observed in fibers from
both normal and overloaded muscles (Figure 2B and 2C) (see also
[12,13]).
Cytoplasmic localization
SMPX-EGFP had a patchy localization in the cytoplasm of the
myoblasts, (Figure 2A). This is in contrast to Palmer et al. (2001),
who found a different GFP-SMPX fusion protein localized to the
leading end of lamellipodia and at focal adhesions.
Muscles from adult rats transfected with the SMPX-EGFP
fusion protein were excised and immediately placed under the
Figure 2. SMPX-EGFP was excluded from all myonuclei. A)
C2C12 myoblasts expressing either EGFP or SMPX-EGFP stained with
Hoechst 33342 to visualize nuclei. B) In vitro confocal image of dissected
single rat EDL muscle fibers expressing EGFP or SMPX-EGFP stained
with DAPI to visualize nuclei. C) Confocal images of EDL muscle fibers in
situ, after no treatment (CON) or functional overload for 18 hours
(LOAD), expressing SMPX-EGFP stained with Hoechst 33342 to visualize
nuclei. Myonuclei are labeled with arrowheads. Scale bar is 10 microns.
doi:10.1371/journal.pone.0099232.g002
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microscope for imaging. We found that the protein was forming
thin lines appearing as doublets, the pattern being distinctly
different from the broad, more diffuse lines seen with EGFP alone
(Figure 3A).
To increase the resolution, fibers were fixed, teased, stained with
phalloidin and imaged using confocal microscopy. Similarly as in
the in vivo and in situ experiments, SMPX-EGFP appeared to be
localized in narrow bands flanking the z-discs (Figure 3B),
occasionally with a band overlying the Z-disc itself (data not
shown).
Fiber type and fiber size
The increased levels of SMPX did not result in a change in cross
sectional area (CSA) of the fibers. (Figure 4A). Also, we found no
significant effect on fiber type distribution by overexpressing the
ectopic SMPX protein (Figure 4B).
Discussion
It has previously been postulated that SMPX may serve as a
transcription factor. In our study though, SMPX-EGFP was not
detected above background levels in the nuclei in adult skeletal
muscle, and did not show any nuclear accumulation in C2C12
cells compared to cytoplasmic levels. Our findings are in
agreement with previous cell culture studies of endogenous and
myc-epitope tagged SMPX, that were localized predominantly to
the cytoplasm in C2C12 myocytes and myotubes [13,14]. Also in
agreement with our main finding SMPX appears to be excluded
from multinuclear muscle cells: Kemp and collaborators found
SMPX to be accumulated at varying levels within nuclei of
mononuclear C2C12 cells using immunohistochemistry, but
absent from all nuclei in fused myotubes [12].
To test whether introducing increased mechanical load could
induce nuclear translocation in vivo, we subjected the muscle to
increased load and stretch by synergist ablation (see methods), a
protocol that over time results in substantial hypertrophy [22].
After 18 hours, no visible differences were found between the
normal and the overloaded muscles with regard to nuclear
accumulation of SMPX. Together with our finding that overex-
pression of SMPX in the fast EDL muscle had no effect on either
fiber cross sectional area or fiber type composition (Figure 4) this
speaks against a gene regulatory role for this protein.
We next asked if the subcellular localization of SMPX-EGFP
could be consistent with a role as a mechanosensor. In agreement
with previous staining of fixed tissue [14] we found the SMPX-
EGFP fusion protein to be localized to the level of the costameres
that is aligned with the I-bands, flanking each Z-line. This
localization might be consistent with SMPX working as a
mechanosensor [10].
It remains unclear if SMPX has any major effect on adult
muscle phenotype, directly or indirectly. Our findings demonstrate
that increased levels of SMPX by overexpression in single adult
fibers do not change the fiber type or size. Also, SMPX null-mice
do not show any clear phenotypic alterations in skeletal muscle
[14]. Interestingly, SPMX might play an important role in another
tissue that relies on mechanotransduction, namely the auditory
system. Huebner et al. suggest that SMPX plays a critical role in
protecting against mechanical stress in cells in the organ of Corti as
nonsense mutations in the Smpx gene results in hearing loss in
humans [23,24]. The fact that Rac1, a GTPase activated by
biomechanichal stress, is a major target for SMPX [13] supports
its role as a possible mechanotransducer. Patients from the families
in the Huebner study did not show any obvious signs of muscular
dysfunction [23], and our results demonstrate that overexpression
of the protein does not change fiber type or size. However, it
cannot be excluded that decreased levels of the SMPX protein
could influence adult skeletal muscle, or that it could serve as a
mechanosensor resulting in phenotypic alterations not investigated
in this paper.
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